Insulin Glulisine in Type 2 Diabetes Mellitus

Clinical trial NCT00310297 · COMPLETED

Trial details

NCT number: NCT00310297
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2004-11-01
Primary completion: 2004-12-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.